The route of administration for Rotavirus vaccine is:

NORCET 9 Mains - 2025

Community Health Nursing

Easy

Appeared in: NORCET 9 Mains - 2025

Explanation

The Rotavirus vaccine is a live attenuated vaccine specifically designed for oral administration.
This route mimics the natural path of infection (gastrointestinal), stimulating robust local immunity in the gut where the rotavirus primarily attacks.
The National Immunization Schedule specifies oral drops for the Rotavirus vaccine, given to infants at 6, 10, and 14 weeks.

Option A: The intramuscular route is used for many inactivated and subunit vaccines, but not for Rotavirus. Administering the live Rotavirus vaccine intramuscularly would be incorrect and would not provide the intended gut immunity.
Option C: The subcutaneous route is used for other live attenuated vaccines, but not for Rotavirus. The target for the Rotavirus vaccine is the gastrointestinal mucosa, not the fatty tissue under the skin.
Option D: The intradermal route is used to administer a very small volume of substance into the dermis, primarily for sensitivity testing or for the BCG vaccine. It is not the correct route for the Rotavirus vaccine.

Visual 1: Diagram - A diagram illustrating the different angles of injection for Intradermal (10-15°), Subcutaneous (45°), and Intramuscular (90°) routes to visually differentiate them.
Visual 2: Infographic - An infographic of the National Immunization Schedule (India), highlighting the Rotavirus vaccine with its name, schedule (6, 10, 14 weeks), and oral route of administration.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Vaccine Routes of Administration as background academic context rather than a clinical decision trigger.
Administering a vaccine via the correct route is critical for its efficacy and safety. An incorrect route can lead to vaccine failure or increased local reactions.
A key nursing responsibility is patient education. Parents should be informed about the vaccine schedule and common, mild side effects like fever, irritability, or mild diarrhea.
What if? If an infant has ongoing moderate-to-severe diarrhea or vomiting at the time of a scheduled Rotavirus vaccine dose, the vaccination should be postponed until the illness resolves to ensure the vaccine is effective.

How to Approach the Question

First, identify the core of the question, which is asking for the specific administration route of the Rotavirus vaccine.
This is a factual recall question common in pharmacology and community health nursing. Access your knowledge base about common vaccines.
Recall that Rotavirus causes gastroenteritis. The vaccine logically targets the gut. This points towards an oral route to mimic natural infection and build local immunity.
Evaluate the other options. Associate Intramuscular, Subcutaneous, and Intradermal routes with other common vaccines (e.g., IM for DTP, SC for MMR, ID for BCG) to confirm they are incorrect for Rotavirus.
Select the 'Oral' option as the only logical and correct choice for a vaccine targeting a gastrointestinal pathogen.

Concept Tested & Keywords

Q67WpbzloyhMqrjAynOBl3